Age: 21.0
Sex: F
Vaccine: HPV4
Symptoms: Insomnia, Pain
Clinical narrative: Based upon her chronic and severe post-Gardasil symptoms, Plaintiff has been diagnosed with various medical conditions, including but not limited to, rheumatoid arthritis and fibromyalgia.; Based upon her chronic and severe post-Gardasil symptoms, Plaintiff has been diagnosed with various medical conditions, including but not limited to, rheumatoid arthritis and fibromyalgia.; This initial spontaneous report was received from a lawyer and the consumer regarding a case in litigation and refers to a 21 years-old female patient. The patient's medical history, concurrent conditions and concomitant medications were not reported.   On 16-NOV-2018, the patient was vaccinated with the first dose of quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) strength, lot #, expiry date, and route of administration were not provided) administered for for preventing cervical cancer. It was confirmed that the health care professional through and informed to the patient that the quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) vaccine was safe and effective vaccine for preventing cervical cancer.   On an unknown date, following her quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) vaccination, the patient developed  experienced fatigue, flu-like symptoms, and severe joint pains. As the months progressed, the patient was seen by multiple physicians and specialists for her complaints which now included: fatigue, trouble sleeping, joint pain, hair loss, and body aches. On testing, Petitioner had a positive antinuclear antibody.As a result of her post quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) symptoms, the patient had been unable to engage in activities that a young person her age would normally enjoy, and these symptoms have affected her daily functioning. Prior to receiving the quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) injection, the patient was a healthy and active young mother with goals to become a registered nurse. The patient's plans for her future career and for her family, had been adversely affected.  Based upon her chronic and severe post quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) symptoms, the subject had been diagnosed on unspecified date with various medical conditions, including but not limited to, rheumatoid arthritis and fibromyalgia. Patient contends that her quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) injections caused her to develop serious and debilitating autoimmune including but not limited to, rheumatoid arthritis and fibromyalgia, as well as a constellation of adverse symptoms, complications, injuries, and other adverse events, many of which are alleged herein and all of which were caused by quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) or otherwise linked to her quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) -induced autoimmune disorder. The outcome of all the events was reported as not recovered.  The causality between quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) and all the aforementioned events was reported as related and were also considered as disability events.   The primary reporter considered fibromyalgia as medically significant. Upon internal review, rheumatoid arthritis was determined to be medically significant event.